Glenmede Trust CO Na Csl LTD Transaction History

Glenmede Trust CO Na

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$90.75 - $104.91 $641,602 - $741,713	-7,070 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$77.9 - $98.54 $70,421 - $89,080	904 Added 14.66%	7,070 $685,000
Q3 2019 Nov 14, 2019	BUY	$74.21 - $82.92 $148,345 - $165,757	1,999 Added 47.97%	6,166 $485,000
Q2 2019 Aug 13, 2019	BUY	$68.24 - $75.87 $21,495 - $23,899	315 Added 8.18%	4,167 $314,000
Q1 2019 May 14, 2019	BUY	$65.72 - $71.66 $5,126 - $5,589	78 Added 2.07%	3,852 $266,000
Q4 2018 Feb 14, 2019	BUY	$61.31 - $73.73 $111,032 - $133,525	1,811 Added 92.26%	3,774 $245,000
Q3 2018 Nov 15, 2018	BUY	$71.66 - $82.93 $140,668 - $162,791	1,963 New	1,963 $142,000
Q2 2018 Aug 15, 2018	SELL	$58.93 - $74.24 $110,670 - $139,422	-1,878 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$52.25 - $56.32 $23,408 - $25,231	448 Added 31.33%	1,878 $102,000
Q3 2017 Nov 14, 2017	BUY	$49.7 - $54.38 $71,071 - $77,763	1,430	1,430 $0

141K

Ticker CSLLY
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 964,432,000
Market Cap $97B
Description
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.